Times Now reports the study tied GLP-1 use to 25% lower odds of stroke and 49% lower odds of Alzheimer's. The full findings are at the source.
Recap by typeshit. Post by TIMES NOW on X.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Gold argues the protein, fiber and micronutrient push behind GLP-1 friendly products fills gaps for the general population too, and expects benefit stacking to grow.
Remote visits and easier contact with providers are lowering some of the hurdles to beginning and sticking with GLP-1 care.
Loading…